Turmeric as Treatment in Epilepsy

Withdrawn before enrolling · Not applicable

Conditions studied: Epilepsy, Dravet Syndrome, Lennox-Gastaut Syndrome, Tuberous Sclerosis, Focal Seizures

In brief

This is a single center open-label pilot clinical trial of patients 1-70 years of age with greater than 6 seizures per month diagnosed with Dravet Syndrome, Lennox-Gastaut Syndrome, Tuberous Sclerosis, or focal seizures. Twenty patients will be enrolled and treated with a stable dose of orally administered turmeric oil daily for 3 months. Patients and caregivers will be asked to keep a seizure diary logging all clinical events during the course of the study. Serum comprehensive metabolic panel, complete blood count with differential, and antiseizure medication levels, will be monitored at baseline, 1.5 months, and at the end of 3 months.

Key facts

Study ID

NCT03254680

Run by

NYU Langone Health

People needed

0

Starts

2018-03-01

Expected to finish

2018-11-01

Last updated by the study team

2018-04-30

Who can join

Age: 1 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with greater than greater than six seizures per month diagnosed with Dravet Syndrome, Lennox-Gastaut Syndrome, Tuberous Sclerosis, or focal seizures followed at NYU CEC.

You may not qualify if…

• Patients expected to have changes to any medications or supplements during study period
• exposure to any investigational agent in the month prior to study entry
• pregnant or breast feeding women, positive pregnancy test
• history of non-compliance
• known drug or alcohol dependence
• known baseline hematologic
• liver function
• renal function
• absorption
• absorption

Where it is running

• New York University School of Medicine — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.